The makers of mifepristone, which is part of a two-drug regimen often called “the abortion pill,” asked the Supreme Court on May 2 to allow the prescription medication to be sent in the mail after a lower court blocked it.
The application for an emergency stay was filed one day after the U.S. Court of Appeals for the Fifth Circuit paused a Food and Drug Administration rule that allowed the abortion drug to be mailed.
“Never before has a federal court purported to immediately enjoin a several years’ old drug approval; restrict a distribution system for that drug that manufacturers, providers, patients, and pharmacies have all been using for years; or reinstate conditions that FDA determined do not meet the mandatory statutory criteria,” lawyers for Danco Laboratories LLC expressed in court documents reviewed by The Epoch Times….